Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.28
0.00 (0.00%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$752,000
Profits / Employee
-$9,556
Market Cap
427.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 900 | 0 | - |
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 1,128 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 350 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Alpha Teknova | 158 |
EBS News
- 6 days ago - Emergent BioSolutions awarded $52.7M contract modification - TheFly
- 6 days ago - Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government - GlobeNewsWire
- 12 days ago - BioMendics Receives FDA Fast Track Designation for BM-3103 (TolaSure® Gel™) for Epidermolysis Bullosa Simplex - Business Wire
- 27 days ago - Emergent BioSolutions Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day to Help Save Lives from Opioid Overdose - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Emergent BioSolutions awarded $64.5M HHS contract modification - TheFly
- 5 weeks ago - Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy - GlobeNewsWire